Several generic drugmakers that will produce versions of Pfizer's COVID-19 antiviral treatment Paxlovid have agreed to sell the medicine in low- and middle-income countries for $25 a course or ...

A new report in the Journal of the American Medical Association finds the generic drug market is growing in many countries, including Australia, Belgium and Canada. KYW medical editor Dr. Brian ...

A handful of the largest purveyors of generic medicines have made only halting progress to ensure their drugs are accessible for patients in low- and middle-income countries, a new analysis found.

The move will give 95 lower-income countries access to a generic version of Pfizer’s oral Covid-19 antiviral treatment. Newsletters Games Share a News Tip. Featured. Featured. Breaking News.

On Friday, Novartis' Sandoz revealed that it has launched its generic version of the medicine in 19 countries in Europe. German generics maker Stada Arzneimittel also has launched its Revlimid ...

Poor countries are allowed to import generic medicines, World Trade Organization (WTO) Director General Roberto Azevedo told Reuters on Monday, after the required two-thirds of members agreed a ...